RGNX Earnings Regenxbio Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.72 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -3.76 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -2.46 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.26 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.12 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -4.59 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -3.59 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -2.41 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -1.38 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -6.02 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -4.60 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.19 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.53 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -6.50 | 2025-03-13 | 10-K |
| Q3 2023 | 2022-09-30 | -5.11 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -3.37 | 2023-08-02 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.79 | 2023-05-03 | 10-Q |
| FY 2023 | 2021-12-31 | 2.91 | 2024-02-27 | 10-K |
| Q3 2022 | 2021-09-30 | -3.93 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -2.56 | 2022-08-03 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.